BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory
05 6월 2023 - 7:30PM
BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or
the "Company"), a digital technology company using machine learning
to usher in a new era of precision medicine, today announced
the expansion of its worldwide license agreement with the Johns
Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for
use of patented technology powering the Company’s bfLEAP™ platform,
an AI-driven platform for analyzing drug development data to
potentially make life-saving therapies and treatments available to
patients more quickly.
“We are committed to firmly establishing
BullFrog AI as the undisputed leader in artificial
intelligence-driven drug development,” said Vin Singh, Founder and
CEO of BullFrog AI. "Our expanded license with APL is a testament
to our relentless pursuit of innovation, enabling us to harness the
full potential of AI in accelerating the development of life-saving
therapies. This breakthrough technology not only has the potential
to disrupt the industry, but also transform countless lives across
the globe."
The patented technology from APL powering
bfLEAP™ includes analytical models that enable the analysis and
interpretation of large, complex, and diverse datasets that may be
incomplete and comprise both numerical and categorical data and
provide explainable results. The innovative technology, which
enables the detection of anomalies, patterns, and relationships,
has been shown to perform better than well-known algorithms in
benchmarking tests.
The latest APL license improvements enable
bfLEAP™ capabilities to be much more robust, both from a software
perspective and mathematically. Additionally, the introduction of
multivariate diffuse indexing, a new algorithm for analysis of
mixed categorical/numerical data that supports both link inference
and probabilistic modeling, allows probabilistic models to work
with mixed data without any additional transformation.
Furthermore, the creation of a new repository
that now houses all of the graph algorithms has led to a more
organized structure with three equivalent-sized repositories
containing around 80 runnable analytics each. This update brings
numerous robustness and usability improvements to the platform.
BullFrog AI is deploying bfLEAP™ for use at
several critical stages of therapeutics development with the
intention of streamlining data analytics, decreasing the overall
development costs by decreasing failure rates for new therapeutics
and impacting the lives of countless patients that may otherwise
not receive the therapies they need.
About BullFrog AI
BullFrog AI is a digital technology company
using machine learning to usher in a new era of precision medicine.
Through its collaborations with leading research institutions,
including Johns Hopkins University, BullFrog AI is at the forefront
of AI-driven drug development. Using its proprietary bfLEAP™
artificial intelligence platform, BullFrog AI aims to enable the
successful development of pharmaceuticals and biologics by
predicting which patients will respond to therapies in development.
BullFrog AI is deploying bfLEAP™ for use at several critical stages
of development with the intention of streamlining data analytics in
therapeutics development, decreasing the overall development costs
by decreasing failure rates for new therapeutics, and impacting the
lives of countless patients that may seek to receive the therapies
they need.
For more information, visit BullFrogAI at
Website: www.bullfrogai.com
LinkedIn: https://www.linkedin.com/company/bullfrogai/
Safe Harbor Statement
This press release contains forward-looking
statements. We base these forward-looking statements on our
expectations and projections about future events, which we derive
from the information currently available to us. Such
forward-looking statements relate to future events or our future
performance, including: our financial performance and projections;
our growth in revenue and earnings; and our business prospects and
opportunities. You can identify forward-looking statements by those
that are not historical in nature, particularly those that use
terminology such as "may," "should," "expects," "anticipates,"
"contemplates," "estimates," "believes," "plans," "projected,"
"predicts," "potential," or "hopes" or the negative of these or
similar terms. In evaluating these forward-looking statements, you
should consider various factors, including: our ability to change
the direction of the Company; our ability to keep pace with new
technology and changing market needs; and the competitive
environment of our business. These and other factors may cause our
actual results to differ materially from any forward-looking
statement. Forward-looking statements are only predictions. The
forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives, may
not occur, and actual events and results may differ materially and
are subject to risks, uncertainties, and assumptions about us. We
are not obligated to publicly update or revise any forward-looking
statement, whether as a result of uncertainties and assumptions,
the forward-looking events discussed in this press release and
other statements made from time to time by us or our
representatives might not occur.
Contact:
Dave GentryRedChip Companies,
Inc.BFRG@redchip.com800-733-2447
SOURCE: BullFrog AI Holdings,
Inc.
Bullfrog AI (NASDAQ:BFRGW)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bullfrog AI (NASDAQ:BFRGW)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024